Inhibikase Therapeutics Inc (IKT)
1.295
-0.06
(-4.43%)
USD |
NASDAQ |
May 02, 16:00
1.295
0.00 (0.00%)
After-Hours: 16:03
Inhibikase Therapeutics Net Income (Quarterly): -4.178M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.178M |
September 30, 2023 | -4.595M |
June 30, 2023 | -5.778M |
March 31, 2023 | -4.478M |
December 31, 2022 | -4.279M |
September 30, 2022 | -4.495M |
June 30, 2022 | -4.640M |
March 31, 2022 | -4.641M |
December 31, 2021 | -5.042M |
September 30, 2021 | -4.471M |
Date | Value |
---|---|
June 30, 2021 | -2.636M |
March 31, 2021 | -2.637M |
December 31, 2020 | -1.208M |
September 30, 2020 | -0.6706M |
June 30, 2020 | -0.4219M |
March 31, 2020 | -0.5474M |
December 31, 2019 | -0.43M |
September 30, 2019 | -1.212M |
June 30, 2019 | -2.344M |
March 31, 2019 | -1.736M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-5.778M
Minimum
Jun 2023
-0.4219M
Maximum
Jun 2020
-3.090M
Average
-4.178M
Median
Dec 2023
Net Income (Quarterly) Benchmarks
Tenax Therapeutics Inc | -3.226M |
BioRestorative Therapies Inc | -2.825M |
Bio-Path Holdings Inc | -3.372M |
ADMA Biologics Inc | -17.64M |
Hepion Pharmaceuticals Inc | -11.06M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 4.404M |
EPS Diluted (Quarterly) | -0.64 |
Enterprise Value | -4.354M |
Earnings Yield | -275.7% |